|
ABT
|
Abbott Laboratories
|
US
|
NYSE
|
|
AERI
|
Aerie Pharmaceuticals, Inc.
|
US
|
NASDAQ
|
|
ALKS
|
Alkermes plc
|
US
|
NASDAQ
|
|
ASND
|
Ascendis Pharma A/S
|
US
|
NASDAQ
|
|
AVTE
|
Aerovate Therapeutics, Inc.
|
US
|
NASDAQ
|
|
AZN
|
Astrazeneca PLC
|
US
|
NASDAQ
|
|
BLPH
|
Bellerophon Therapeutics, Inc.
|
US
|
NASDAQ
|
|
BMY
|
Bristol-Myers Squibb Company
|
US
|
NYSE
|
|
CINC
|
CinCor Pharma, Inc.
|
US
|
NASDAQ
|
|
CVRX
|
CVRx, Inc.
|
US
|
NASDAQ
|
|
DXR
|
Daxor Corporation
|
US
|
NASDAQ
|
|
EHAB
|
Enhabit, Inc.
|
US
|
NYSE
|
|
EIGR
|
Eiger BioPharmaceuticals, Inc.
|
US
|
NASDAQ
|
|
GILD
|
Gilead Sciences, Inc.
|
US
|
NASDAQ
|
|
ICPT
|
Intercept Pharmaceuticals, Inc.
|
US
|
NASDAQ
|
|
KROS
|
Keros Therapeutics, Inc.
|
US
|
NASDAQ
|
|
LCI
|
Lannett Co Inc
|
US
|
NYSE
|
|
LLY
|
Eli Lilly and Company
|
US
|
NYSE
|
|
LQDA
|
Liquidia Technologies, Inc.
|
US
|
NASDAQ
|
|
MDT
|
Medtronic Inc.
|
US
|
NYSE
|